Waters Co. (NYSE:WAT) Shares Acquired by Summit Trail Advisors LLC

Summit Trail Advisors LLC grew its position in Waters Co. (NYSE:WAT) by 2.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,198 shares of the medical instruments supplier’s stock after purchasing an additional 28 shares during the period. Summit Trail Advisors LLC’s holdings in Waters were worth $431,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. OneDigital Investment Advisors LLC increased its holdings in shares of Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 31 shares during the period. Raymond James Trust N.A. lifted its holdings in Waters by 2.4% in the third quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock valued at $482,000 after acquiring an additional 32 shares during the period. Linscomb Wealth Inc. boosted its position in Waters by 0.4% in the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock worth $2,275,000 after purchasing an additional 34 shares in the last quarter. Johnson Investment Counsel Inc. grew its stake in shares of Waters by 3.2% during the 2nd quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock worth $314,000 after purchasing an additional 34 shares during the period. Finally, Retirement Systems of Alabama increased its holdings in shares of Waters by 0.3% during the 2nd quarter. Retirement Systems of Alabama now owns 13,087 shares of the medical instruments supplier’s stock valued at $3,797,000 after purchasing an additional 37 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Up 2.6 %

Shares of WAT opened at $388.15 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. Waters Co. has a one year low of $273.60 and a one year high of $393.38. The stock has a market capitalization of $23.05 billion, a price-to-earnings ratio of 37.04, a PEG ratio of 6.83 and a beta of 0.97. The stock has a 50 day moving average price of $355.03 and a 200 day moving average price of $332.34.

Waters (NYSE:WAT) last issued its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping the consensus estimate of $2.68 by $0.25. Waters had a return on equity of 49.93% and a net margin of 21.43%. The firm had revenue of $740.30 million during the quarter, compared to analysts’ expectations of $712.99 million. During the same period in the previous year, the business earned $2.84 earnings per share. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. Equities research analysts forecast that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on WAT shares. Leerink Partners raised shares of Waters from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $325.00 to $375.00 in a report on Thursday, August 1st. Sanford C. Bernstein raised their target price on Waters from $345.00 to $360.00 and gave the company a “market perform” rating in a research report on Monday, November 4th. Stifel Nicolaus lifted their price target on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Barclays increased their price target on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $365.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.